# FDA Inspection 1204407 - e+ Oncologics Louisiana LLC - March 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/9195ef73-aede-4a36-a90d-c8a84ad9e111
Source feed: FDA_Inspections

> FDA Inspection 1204407 for e+ Oncologics Louisiana LLC on March 28, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204407
- Company Name: e+ Oncologics Louisiana LLC
- Inspection Date: 2023-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1204407 - 2023-03-28](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/f5cd4d78-4590-4661-ac5e-72d9cc5dbb53)
- [FDA Inspection 743684 - 2011-08-16](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/1c650f4d-60d2-4550-bbf5-c15684a6a493)
- [FDA Inspection 665885 - 2010-05-26](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/8b724d91-42d3-4b5b-b365-8f5e00dece60)

Company: https://www.keypedia.com/companies/e-oncologics-louisiana-llc/116a5a00-402d-411b-ae7d-a95ffeb5b526

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d